Enliven price target lowered to $27 from $36 at JonesResearch

finance.yahoo.com/news/enliven-price-target-lowered-27-164029818.html

In This Article:
JonesResearch analyst Soumit Roy lowered the firm’s price target on Enliven (ELVN) to $27 from $36 and keeps a Buy rating on the shares. The company’s abstract from the Phase 1 late line chronic myeloid leukemia trial with ELVN-001 “was met with a lukewarm initial stock…

This story appeared on finance.yahoo.com, 2025-05-17 16:40:29.
The Entire Business World on a Single Page. Free to Use →